AMN Healthcare Services Inc. (AMN)

57.05
0.15 0.26
NYSE : Commercial Services
Prev Close 56.90
Open 57.15
Day Low/High 56.67 / 57.80
52 Wk Low/High 34.70 / 58.40
Volume 149.20K
Avg Volume 437.60K
Exchange NYSE
Shares Outstanding 47.77M
Market Cap 2.70B
EPS 2.80
P/E Ratio 21.08
Div & Yield N.A. (N.A)

Latest News

Interesting AMN Put And Call Options For February 16th

Investors in AMN Healthcare Services Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMN options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

AMN Healthcare Services Reaches Analyst Target Price

In recent trading, shares of AMN Healthcare Services Inc have crossed above the average analyst 12-month target price of $48.60, changing hands for $50.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AMN Healthcare Awarded Two Additional Sole-Source Contracts With Premier

AMN Healthcare Awarded Two Additional Sole-Source Contracts With Premier

New contracts cover Vendor Management Systems (VMS) and Recruitment Process Outsourcing (RPO) in addition to receiving another three-year contract for staffing services

Predicted Retirement Wave Of Baby-Boomer Nurses Has Hit, AMN Healthcare Survey Shows

Predicted Retirement Wave Of Baby-Boomer Nurses Has Hit, AMN Healthcare Survey Shows

Pressure Will Grow on Nurse Shortages Over the Next Decade

AMN Healthcare Ranks #11 On Fortune 100 Fastest Growing Companies

AMN Healthcare Ranks #11 On Fortune 100 Fastest Growing Companies

Impressive three-year performance for revenue, profits and stock returns

Staffing Industry Analysts Names AMN Healthcare As The Largest U.S. Healthcare Staffing Firm

Staffing Industry Analysts Names AMN Healthcare As The Largest U.S. Healthcare Staffing Firm

Annual Industry List Ranks U.S. Healthcare Staffing Firms by Revenue, Recognizes AMN in Top Spot for Second Consecutive Year

Texas Healthcare Trustees Selects AMN Healthcare Director Andy Stern As Advocate Of The Year

Texas Healthcare Trustees Selects AMN Healthcare Director Andy Stern As Advocate Of The Year

Award recognizes leadership, dedication and commitment

Short Interest In AMN Healthcare Services Jumps 13.5%

The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 862,978 share increase in total short interest for AMN Healthcare Services Inc , to 7,265,797, an increase of 13.48% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Putting 2 Names Back in the Bullpen

We're removing Dycom and AMN Healthcare from the portfolio.

Our Strategy on AMN Healthcare

Why have we have held off (so far) from adding shares during the recent pullback.

Trifecta Stocks Weekly Roundup

The market's roller-coaster week included its worst one-day decline in several months.

Trifecta Stocks Weekly Roundup

In a mixed week for the markets, several portfolio positions significantly outperformed.

AMN Healthcare Services: Cramer's Top Takeaways

AMN Healthcare Services: Cramer's Top Takeaways

Susan Salka, president and CEO of AMN Healthcare Services, tells Jim Cramer about looming shortage of doctors and nurses.

The Kids Are Taking Over the World: Cramer's 'Mad Money' Recap (Thursday 5/11/17)

The Kids Are Taking Over the World: Cramer's 'Mad Money' Recap (Thursday 5/11/17)

Jim Cramer says too many companies don't understand milliennials as a consumer group -- and it's killing traditional retail.

Trifecta Stocks Weekly Roundup

We updated price targets on several portfolio positions amid a torrent of earnings reports, data and activity in D.C.

AMN Healthcare Results Beat Estimates

Second-quarter guidance is a bit below expectations.

TheStreet Quant Rating: A (Buy)